NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr21.78%1,986,304$1.18MInsider
Regional Medical Center Yuma19.90%1,814,375$1.07MInsider
Princeton Capital Corp14.19%1,293,814$765.94kInsider
Stanley Westreich13.09%1,193,281$706.42kInsider
Karl Johe10.20%930,373$550.78kInsider
Robert J. Trenschel3.46%315,399$186.72kInsider
Sandford D. Smith2.41%219,916$130.19kInsider
John Conron1.27%115,492$68.37kInsider
Catherine A. Sohn1.17%106,952$63.32kInsider
Scott Varde Ogilvie0.94%86,020$50.92kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI0.93%90.65%
KTTA2.86%97.14%Net Selling
CMND10.96%0.00%
BCTX1.35%98.65%
SPRB9.69%90.31%Net Selling

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 0.93% institutional shareholders, 90.65% Palisade Bio insiders, and 8.42% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 21.78% of the company. Richard Garr's Palisade Bio shares are currently valued at $1.20M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.